Skip to main content

Zee Peptides research references

The original papers and reviews, with a few places to begin.

Structure and wound experiments

The opening actin-sequestration paper gives the molecular interaction its shape. The 1999 rat wound study moves into tissue measurements, and the thymosin beta-4 review gathers the broader repair biology. The rat stroke study supplies a useful reminder that experimental responses can vary across tested amounts.

GHK-Cu, BPC-157 and KPV papers

For GHK-Cu, begin with the 2015 skin-regeneration review and 2008 tissue-remodelling review. The GHK gene-data review concerns cellular programmes. BPC-157’s vascular mechanism study and rat Achilles experiment ask different repair questions. The KPV intestinal-transport paper explains the gut-cell setting behind the KLOW discussion.

Human observations and overviews

The two-adult BPC-157 safety pilot and 40-volunteer full thymosin beta-4 trial identify their participants and experimental materials. The 2025 BPC-157 narrative review and 2026 sports-medicine review place those small human datasets within the wider literature. The complete citation list follows.

  1. Mendias CL, Awan TM. Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance. Sports Medicine. 2026. ↗
  2. McGuire FP, Martinez R, Lenz A, Skinner L, Cushman DM. Regeneration or Risk? A Narrative Review of BPC-157 for Musculoskeletal Healing. Current Reviews in Musculoskeletal Medicine. 2025. ↗
  3. Hsieh MJ, et al. Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation. Journal of Molecular Medicine (Berlin). 2017;95:323-333. ↗
  4. Pickart L, Vasquez-Soltero JM, Margolina A. GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration. BioMed Research International. 2015;2015:648108. ↗
  5. Pickart L. The human tri-peptide GHK and tissue remodeling. Journal of Biomaterials Science, Polymer Edition. 2008;19(8):969-988. ↗
  6. Lee E, Burgess K. Safety of Intravenous Infusion of BPC157 in Humans: A Pilot Study. Altern Ther Health Med. 2025;31(5):20-24. ↗
  7. Pickart L, Margolina A. Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. International Journal of Molecular Sciences. 2018;19(7):1987. ↗
  8. Dalmasso G, Charrier-Hisamuddin L, Nguyen HT, Yan Y, Sitaraman S, Merlin D. PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation. Gastroenterology. 2008;134(1):166-178. ↗
  9. Staresinic M, et al. Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon and in vitro stimulates tendocytes growth. J Orthop Res. 2003;21:976-983. ↗
  10. Malinda KM, et al. Thymosin beta4 accelerates wound healing. J Invest Dermatol. 1999. ↗
  11. Morris DC, et al. A dose-response study of thymosin β4 for the treatment of acute stroke. J Neurol Sci. 2014. ↗
  12. Goldstein AL, Hannappel E, Sosne G, Kleinman HK. Thymosin β4: a multi-functional regenerative peptide. Basic properties and clinical applications. Expert Opin Biol Ther. 2012. ↗
  13. Ruff D, et al. A randomized, placebo-controlled, single and multiple dose study of intravenous thymosin β4 in healthy volunteers. Ann N Y Acad Sci. 2010. ↗
  14. Irobi E, et al. Structural basis of actin sequestration by thymosin-beta4: implications for WH2 proteins. EMBO J. 2004. ↗